3D Printed Medical Devices Market By Product (3D printers, 3D bio-printers, materials, software & services), By Application (Implants, tissue engineering, and external wearable device), By Technology (Laser beam melting, photo polymerization, 3D printing, electron beam melting and droplet deposition), By end user (hospitals, academic institutes, CRO’s and Pharma & biotech companies) and Geography

 

3D Printed Medical Devices Market size is valued at USD 1.54 billion in 2021 and is expected to reach USD 2.42 billion by 2028 at a CAGR of 18.8% during 2022-2028. The low growth is mainly due to lockdowns imposed by governments around the world, which impeded the supply chain in the manufacturing sector of medical devices. Growing demand for organ transplants over the forecast period is expected to fuel growth in the global market for 3D printed medical devices. For example, according to the Healthcare Systems Bureau of Health Resources and Services Administration, as of July 2019 more than 113,000 people are on the U.S. national transplant waiting list. Less materials is appropriate for medical device 3D printing which is expected to inhibit market development. Additionally, the small size of 3D printers limits the size of the finished product which might not be feasible for the development of parts of large industrial machinery. This in turn is expected to hinder business growth. This study analyses the global market dynamics in a detailed manner to identify current trends and drivers, growth opportunities and potential challenges to the key stakeholders in the operating market. In addition, PBI has analyzed the global market to better equip customers with possible investment opportunities across region and consumer unmet needs. Key Development In Mar 2022, 3D Systems and Enhatch partnered to deliver 3D printed medical devices. The firms will combine their respective skills and technologies to develop an optimized, automated, and scalable workflow for fabricating medical devices as part of the agreement. In Jan 2021, ZARE acquired Proxera. ZARE is uniquely well-positioned to address a growing demand for customisable patient-specific medical implants as a result of the acquisition.